Epidermal growth factor receptor — Drug Target

All drugs that target Epidermal growth factor receptor — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Kinase Inhibitor [EPC] · Kinase Inhibitor · Epidermal Growth Factor Receptor Antagonist [EPC]

Marketed (10)

• Gilotrif · Boehringer Ingelheim · Kinase Inhibitor [EPC] · Oncology
  Gilotrif works by blocking the epidermal growth factor receptor, a protein that helps cancer cells grow.
• Tykerb · Novartis · Kinase Inhibitor · Oncology
  Tykerb works by blocking the epidermal growth factor receptor, a protein that promotes cancer cell growth.
• Iressa · Pfizer Inc. · Kinase Inhibitor [EPC] · Oncology
  Iressa blocks the epidermal growth factor receptor (EGFR) signaling pathway, preventing cancer cell growth and proliferation.
• ICOTINIB · Zhejiang Beta Pharma Inc. · Oncology
• Erbitux · Imclone · Epidermal Growth Factor Receptor Antagonist [EPC] · Oncology
  Erbitux works by binding to the Epidermal Growth Factor Receptor (EGFR) on cancer cells, blocking the receptor's ability to stimulate cell growth and division.
• Portrazza · Eli Lilly Co · Epidermal Growth Factor Receptor Antagonist [EPC] · Oncology
  Portrazza works by blocking the epidermal growth factor receptor (EGFR) protein, which is involved in cancer cell growth and proliferation.
• Tarceva · Osi Pharms · Kinase Inhibitor · Oncology
  Tarceva works by blocking the epidermal growth factor receptor, a protein that helps cancer cells grow.
• Vizimpro · Pfizer · Oncology
  Vizimpro works by blocking the EGFR tyrosine kinase, a protein that helps cancer cells grow and survive.
• vectibix · Centre Jean Perrin · Oncology
• Erbitux · Hellenic Oncology Research Group · Oncology